Reliance Industries (RIL) shares will remain in focus on Monday after the company on Saturday announced the acquisition of technology-led oncology platform Karkinos Healthcare for Rs 375 crore ...

Most recently, RIL acquired oncology platform Karkinos Healthcare for Rs 375 crore, expanding its footprint in digital and diagnostic healthcare, PTI reported, citing a Morgan Stanley report.

The development follows the approval of a resolution plan for Karkinos Healthcare by NCLT after it entered the Corporate Insolvency Resolution Process (CIRP) in May. Tata Group to invest Rs 110 ...

Recent acquisition Karkinos Healthcare boosts its digital healthcare presence. Major investments include Hathway Cable and REC Solar. RIL aims to enhance its healthcare services using advanced ...

Last week, Reliance bought oncology platform Karkinos Healthcare for ₹375 crore, adding another stack to its diagnostic and digital healthcare ecosystem, Morgan Stanley said in a report.

Last week, Reliance bought oncology platform Karkinos Healthcare for Rs 375 crore, adding another stack to its diagnostic and digital healthcare ecosystem, Morgan Stanley said in a report.

Reliance Industries, through its subsidiary RSBVL, has acquired the oncology-focused platform Karkinos for Rs 375 crore. Karkinos provides technology-driven cancer care solutions and aims to offer ...

Last week, Reliance bought oncology platform Karkinos Healthcare for Rs 375 crore, adding another stack to its diagnostic and digital healthcare ecosystem, Morgan Stanley said in a report.

Photograph: PTI Photo from the Rediff Archives Last week, Reliance bought oncology platform Karkinos Healthcare for Rs 375 crore, adding another stack to its diagnostic and digital healthcare ...